284 related articles for article (PubMed ID: 31374181)
1. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes.
Paterno MT; Jablonski L; Klepacki A; Friedmann PD
J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181
[TBL] [Abstract][Full Text] [Related]
2. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
Pritham UA; Paul JA; Hayes MJ
J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
[TBL] [Abstract][Full Text] [Related]
3. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
4. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
[TBL] [Abstract][Full Text] [Related]
5. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
[TBL] [Abstract][Full Text] [Related]
6. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
[TBL] [Abstract][Full Text] [Related]
7. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads.
Schiff DM; Wachman EM; Philipp B; Joseph K; Shrestha H; Taveras EM; Parker MGK
Breastfeed Med; 2018 May; 13(4):266-274. PubMed ID: 29630387
[TBL] [Abstract][Full Text] [Related]
8. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
Debelak K; Morrone WR; O'Grady KE; Jones HE
Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
[TBL] [Abstract][Full Text] [Related]
11. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
Wang S; Meador KJ; Pawasauskas J; Lewkowitz AK; Ward KE; Brothers TN; Hartzema A; Quilliam BJ; Wen X
Drug Saf; 2023 Mar; 46(3):257-271. PubMed ID: 36642778
[TBL] [Abstract][Full Text] [Related]
12. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
[No Abstract] [Full Text] [Related]
13. Opioid Use Disorder and Perinatal Outcomes.
Piske M; Homayra F; Min JE; Zhou H; Marchand C; Mead A; Ng J; Woolner M; Nosyk B
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34479983
[TBL] [Abstract][Full Text] [Related]
14. The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.
Wine O; McNeil D; Kromm SK; Foss K; Caine V; Clarke D; Day N; Johnson DW; Rittenbach K; Wood S; Hicks M
BMC Health Serv Res; 2023 May; 23(1):448. PubMed ID: 37149626
[TBL] [Abstract][Full Text] [Related]
15. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
[TBL] [Abstract][Full Text] [Related]
16. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
Metz V; Jagsch R; Ebner N; Würzl J; Pribasnig A; Aschauer C; Fischer G
Hum Psychopharmacol; 2011 Aug; 26(6):412-21. PubMed ID: 21823171
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy.
Mittal L; Suzuki J
Subst Abus; 2017; 38(3):261-264. PubMed ID: 26672650
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Association between Prenatal Care Visits and Adverse Perinatal Outcome in Pregnancies Complicated by Opioid Use Disorder.
Pinchman EV; Lende MN; Feustel P; Lynch T
Am J Perinatol; 2024 May; 41(S 01):e2225-e2229. PubMed ID: 37286184
[TBL] [Abstract][Full Text] [Related]
19. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
20. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
